5 Einträge gefunden

1. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group

   1. Escherich, Gabriele
   2. Zur Stadt, Udo
   3. Borkhardt, Arndt
   4. Dilloo, Dagmar
   5. Faber, Jörg
   6. Feuchtinger, Tobias
   7. Imschweiler, Thomas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial

   1. Mezger, Kerstin
   2. Ebert, Sabine
   3. Muhle, Hannah Elisa
   4. Stadt, Udo Zur
   5. Borkhardt, Arndt
   6. Dilloo, Dagmar
   7. Faber, Jörg

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09

   1. Schramm, Franziska
   2. Zimmermann, Martin
   3. Jorch, Norbert
   4. Pekrun, Arnulf
   5. Borkhardt, Arndt
   6. Imschweiler, Thomas
   7. Christiansen, Holger

   2019 - Forschungsinformationssystem des UKE
4. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

   1. Schramm, Franziska
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Jorch, Norbert
   5. Pekrun, Arnulf
   6. Borkhardt, Arndt
   7. Imschweiler, Thomas

   2019 - Forschungsinformationssystem des UKE
5. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

   1. Escherich, Gabriele
   2. Troeger, Anja F
   3. Gobel, Ulrich
   4. Graubner, Ulrike
   5. Pekrun, Arnulf
   6. Jorch, Norbert
   7. Kaspers, Gjl

   2011 - Forschungsinformationssystem des UKE - frei zugänglich